During the past decade, Centre Hospitalier de Pau conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 14 clinical trials were completed, i.e. on average, 16.5% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 11 clinical trials were completed. i.e. 31.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Pau" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 19 trials, followed by "Federation Francophone de Cancerologie Digestive" with 10 trials sponsored, "Boston Scientific Corporation" with 9 trials sponsored, "University Hospital, Bordeaux" with 9 trials sponsored and "Centre Hospitalier de PAU" with 9 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Pau" #1 collaborator was "Ministry of Health, France" with 5 trials as a collaborator, "UNICANCER" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Pau" are "Colorectal Cancer" (6 trials), "Coronary Artery Disease" (6 trials), "Breast Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials) and "Heart Failure" (4 trials). Many other conditions were trialed in "Centre Hospitalier de Pau" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Pau" are "Drug" (71 trials), "Device" (28 trials), "Procedure" (21 trials), "Other" (20 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Carboplatin" (6 trials), "Bevacizumab" (5 trials), "Paclitaxel" (5 trials) and "fluorouracil" (5 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Pau" are 137 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Pau". 3 are not yet recruiting, 21 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 91 completed trials in Centre Hospitalier de Pau, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Pau, 0 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 21 trials that are defined as “Not Applicable".

Centre Hospitalier de Pau has several departments that took part in Clinical trials: "Ch Francois Mitterrand; Medecine Oncologie" - 3 trials, "CH PAU - Service de Médecine interne et Maladies infectieuses" - 2 trials